Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Bavarian Nordic — November 2019

Planlagt Fastgjort Låst Flyttet Bavarian Nordic
112 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #52

    1

    1 Reply Last reply
    0
    • J Offline
      J Offline
      Jazzz
      wrote on sidst redigeret af
      #53

      Unge.. se 27-30/10 der taler vi om mulig slut kurs.. (3sider tilbage i chatten)

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #54

        Shorts stiger i Bavarian: https://www.proinvestor.com/investornyt/648286/stigning-i-shortposition-i-bampo-og-bavarian-ellers-fald-i-shorts

        1 Reply Last reply
        0
        • N Offline
          N Offline
          Nike
          wrote on sidst redigeret af
          #55

          Hvad er forventningerne til Zealands regnskab på torsdag? Anyone?

          1 Reply Last reply
          0
          • M Offline
            M Offline
            m00t
            wrote on sidst redigeret af
            #56

            Merck får præ-godkendt deres ebola vaccine i Europa. Nogen der har en ide om hvad effekten af at være først

            1 Reply Last reply
            0
            • M Offline
              M Offline
              m00t
              wrote on sidst redigeret af
              #57

              .. på markedet har af betydning for eks Bava?

              1 Reply Last reply
              0
              • M Offline
                M Offline
                m00t
                wrote on sidst redigeret af
                #58

                Link Preview Image
                Ebola vaccine approved in Europe in landmark moment in fight against a deadly disease

                The European Commission granted marketing authorization to Merck’s vaccine, giving the world for the first time an approved vaccine against Ebola.

                favicon

                STAT (www.statnews.com)

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  kkjoel
                  wrote on sidst redigeret af
                  #59

                  Rigtig
                  fin nyhed: BAVA tager vaccine-salgs-topmanden fra GSK - Jean-Christophe May, Global Vaccines Commercialization Leader - samtidigt med vaccinerne. Han må være en af dem, der ved mest om vaccinerne og hvordan man bør gribe (intensiveret) markedsføring an.

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    kkjoel
                    wrote on sidst redigeret af
                    #60

                    Link Preview Image
                    News | Bavarian Nordic

                    Bavarian Nordic - a pioneering force in vaccines – expanding our reach and impact through life-changing solutions

                    favicon

                    (www.bavarian-nordic.com)

                    1 Reply Last reply
                    0
                    • M Offline
                      M Offline
                      m00t
                      wrote on sidst redigeret af
                      #61

                      Enig, det er en rigtig god nyhed og en stor kapacitet i forhold til der kommercielle rejse Bava skal på i de kommende år.

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        BioBio
                        wrote on sidst redigeret af
                        #62

                        @m00t. BAVA. Da Mercks og Janssens/BNs Ebola-vaccine kommer til at have forskellige fordele/ulemper, kommer det nok ikke til at betyde det helt store rent kommercielt
                        at være først.

                        1 Reply Last reply
                        0
                        • N Offline
                          N Offline
                          Nike
                          wrote on sidst redigeret af
                          #63

                          Det ser ud til, at Zealand
                          regnskabet lander kl. 16.00.

                          1 Reply Last reply
                          0
                          • collersteenC Offline
                            collersteenC Offline
                            collersteen
                            wrote on sidst redigeret af
                            #64

                            Blot en lille servicemeddelse om at man kan møde Bavarian ved selvsyn d. 21. november og stille spørgsmål. https://www.eventbrite.co.uk/e/kapitalmarkedseftermiddag-2111-2019-nu-med-astralis-ogsa-tickets-79684958857

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #65

                              Podcast med Zealand: https://www.proinvestor.com/index.php?p=debat_1&postid=79181

                              1 Reply Last reply
                              0
                              • V Offline
                                V Offline
                                ValueHunterDK
                                wrote on sidst redigeret af
                                #66

                                favicon

                                (finance.yahoo.com)

                                1 Reply Last reply
                                0
                                • V Offline
                                  V Offline
                                  ValueHunterDK
                                  wrote on sidst redigeret af
                                  #67

                                  Zealand Pharma completes Phase 3 clinical program for HypoPal® rescue pen, initiates a new Phase 2 clinical proof of concept trial with dasiglucagon, and secures DKK 560 million in additional investment

                                  1 Reply Last reply
                                  0
                                  • V Offline
                                    V Offline
                                    ValueHunterDK
                                    wrote on sidst redigeret af
                                    #68

                                    Sikke en nyhed lige inden regnskab

                                    1 Reply Last reply
                                    0
                                    • V Offline
                                      V Offline
                                      ValueHunterDK
                                      wrote on sidst redigeret af
                                      #69

                                      Financial results for the first nine months of 2019

                                      Revenue DKK 29.8 million / USD 4.4 million (DKK 24.9 million / USD 3.9 million in the first nine months of 2018).
                                      Net operating expenses DKK 431.5 million / USD 62.9 million (DKK 330.6 million / USD 51.3 million in the first nine months of 2018).
                                      Net operating result DKK –402.1 million / USD –58.7 million (DKK 797.5 million / USD 123.8 million in the first nine months of 2018).
                                      Cash including marketable securities amounted to DKK 1,543.2 milli

                                      1 Reply Last reply
                                      0
                                      • exitnuE Offline
                                        exitnuE Offline
                                        exitnu
                                        wrote on sidst redigeret af
                                        #70

                                        JA, godkendt af markedet ... 🙂

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #71

                                          +4,94% op idag!

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger